Skip to main content
OpenTrials

Clinical trial condition

Opioid Use Disorder, Moderate

Explore clinical trials studying Opioid Use Disorder, Moderate. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Opioid Use Disorder, Moderate trial results

Recruiting

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

NCT06651177

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Gateway Community Services Jacksonville, Florida, United States
  • IBIS Behavioral Health Tampa, Florida, United States
  • Ruth M. Rothstein CORE Center Chicago, Illinois, United States
  • The Gibson Center for Behavioral Change Cape Girardeau, Missouri, United States
View Trial Details
Not Yet Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States
  • HIPS Washington D.C., District of Columbia, United States
  • CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States
  • Harm Reduction Sisters Duluth, Minnesota, United States
View Trial Details
Completed

EXHIT ENTRE Comparative Effectiveness Trial

NCT04345718

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston University Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

NCT04921787

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Boston University Boston, Massachusetts, United States
  • Hennepin Healthcare Research Institute Minneapolis, Minnesota, United States
  • New York University New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details

Related conditions